Follow The Filings

GGAL

Earnings company data as of 4:49 AM ET 10/23

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 24 Nov EPS 1.17 — —
Rev — — —
FY2026 Q2 25 Aug EPS 0.90 — —
Rev — — —

Insider trades

Open-market buys and sales by GGAL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GGAL insider trades
  • $4.3M bought by 1 insider
  • $188K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Tomas Braun Director
    Sale
    $188K 39,562 shares at $4.75 13% of stake
    Traded Mar 20–Sep 14 Filed Oct 5
    ↗
  2. Silvestre Vila Moret Director
    Buy
    $2.2M 399,824 shares at $5.40 +15% to stake
    Traded Jul 7–8 Filed Jul 13
    ↗
  3. Silvestre Vila Moret Director
    Buy
    $2.1M 402,967 shares at $5.19 +18% to stake
    Traded Jun 26–Jul 7 Filed Jul 9
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
20-F Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc

Source: SEC EDGAR submissions, updated 18 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.